RLMD

Let's plunge into the spicy financial salsa of RELMADA THERAPEUTICS, INC. without further ado. Agreed, quarterly review documents can be blander than overcooked pasta, but that's where gem-like opportunities usually hide. Dishing out laughter but not profits, RELMADA in Q3 of fiscal 2023, reported a monumental net loss of $22,002,058. What springs out from these numbers is their remarkable investment in future payoffs, with a whopping $10,454,072 parked in research and development. Cast your eyes upon the balance sheet, RELMADA commands total assets worth $109,148,853, majorly stacked as current assets. Although that might cause furrowed brows, wonder why? Because a spectacular $106,267,101 lies dormant as 'other current assets'. While some view this as frozen capital, to us, it's an adventurer's map to uncover the true character of its balance sheet. The equilibrium on the balance sheet sees an equally impressive equity of $100,726,635. Liabilities are minuscule, relative to the assets at $8,422,218. Though, an investor should tread with caution given the conspicuous absence of non-current liabilities. Yup, zero. This could signal an undrawn debt capacity or a forewarning of potential future debt. Amid the whirlpool of numbers, be wary of the basic earnings per share drowned at -$0.73, even worse when attempted at dilution, sinking further to -$1.31. To an untrained eye, this might sound the alarms. However, for us Sherlock's of finance, this presents an intriguing opportunity to delve into the causes behind these stormy numbers. The cash flow statement is a mixed bag. While the net cash flow from operating activities is in the red at -$11,631,129, the firm managed a fair uptick from financing activities presenting a strong cash inflow of $7,770,755. Shrewd investors know this could be a company's tactic to keep the ship afloat in rough waters or a strategic maneuver to accelerate growth plans. Lastly, the comprehensive income loss, bearing the imprint of the net loss at $22,002,058, quietly whispers a cautionary tale. Yet, it's a known fact, like the Phoenix rising from the ashes, many a great company have charted their success story following a string of losses. To wrap it up, the soup might look murky, but, hey, remember that pearl takes time to form inside an unassuming oyster. Every bit 'mada from the heart, it will be fascinating to watch which way RELMADA unfolds.

Check out the detailed filing here!